Surmodics reported $-2384000 in Operating Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbott ABT:US $ 1342M 767M
Align Technology ALGN:US $ 268.9M 43.46M
Anika Therapeutics ANIK:US $ 9.18M 7.92M
Arrowhead Research ARWR:US $ -31868000 3.64M
Baxter International BAX:US $ 424M 34M
Bioscrip BIOS:US $ 48.09M 6.6M
Boston Scientific BSX:US $ 262M 108M
Cryolife CRY:US $ 1.32M 0.12M
Edap Tms EDAP:US $ -0.43M 0.67M
Edwards Lifesciences EW:US $ 542.1M 158.6M
Genmark Diagnostics GNMK:US $ -2.09M 0.82M
Haemonetics HAE:US $ 1.39M 22.56M
Heron Therapeutics HRTX:US $ -60.47M 8.36M
Johnson & Johnson JNJ:US $ 6662M 767M
Merit Medical Systems MMSI:US $ 8.9M 5.3M
Mesa Laboratories MLAB:US $ 3.12M 1.17M
Nektar Therapeutics NKTR:US $ -110.2M 0.81M
Oxford Immunotec Global OXFD:US $ 0.28M 10.11M
Providence Service PRSC:US $ 27.57M 1.25M
Stryker SYK:US $ 729M 259M
Surmodics SRDX:US $ -2.38M 11.87M